Total Payments
$1,515
2024 Payments
$199.48
Companies
13
Transactions
42
Medicare Patients
2,503
Medicare Billing
$341,917
Payment Breakdown by Category
Food & Beverage$1,328 (87.7%)
Education$186.83 (12.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,328 | 35 | 87.7% |
| Education | $186.83 | 7 | 12.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $382.55 | 14 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $336.68 | 6 | $0 (2018) |
| ABBVIE INC. | $191.39 | 4 | $0 (2024) |
| Mentor Worldwide LLC | $152.79 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $129.98 | 2 | $0 (2017) |
| Gilead Sciences, Inc. | $120.51 | 1 | $0 (2019) |
| Insmed, Inc. | $47.73 | 2 | $0 (2023) |
| Janssen Biotech, Inc. | $43.78 | 2 | $0 (2022) |
| ViiV Healthcare Company | $39.36 | 2 | $0 (2021) |
| Stryker Corporation | $22.04 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $199.48 | 7 | Mentor Worldwide LLC ($152.79) |
| 2023 | $182.98 | 4 | AbbVie Inc. ($166.74) |
| 2022 | $315.26 | 8 | Allergan, Inc. ($271.48) |
| 2021 | $70.85 | 3 | ViiV Healthcare Company ($39.36) |
| 2020 | $41.79 | 3 | Allergan, Inc. ($41.79) |
| 2019 | $174.21 | 4 | Gilead Sciences, Inc. ($120.51) |
| 2018 | $230.18 | 2 | Merck Sharp & Dohme Corporation ($230.18) |
| 2017 | $300.55 | 11 | Astellas Pharma US Inc ($129.98) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Mentor Worldwide LLC | MENTOR MemoryGel Resterilizable Gel Sizer (Device) | Food and Beverage | In-kind items and services | $111.21 | General |
| Category: Plastic Surgery | ||||||
| 11/05/2024 | Mentor Worldwide LLC | MENTOR CPX 2 Breast Tissue Expander (Device) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Plastic Surgery | ||||||
| 09/05/2024 | Mentor Worldwide LLC | MENTOR CPX 2 Breast Tissue Expander (Device) | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: Plastic Surgery | ||||||
| 08/20/2024 | Mentor Worldwide LLC | MENTOR CPX 2 Breast Tissue Expander (Device) | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: Plastic Surgery | ||||||
| 07/25/2024 | ABBVIE INC. | ALLODERM (Device) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: PLASTIC SURGERY | ||||||
| 07/23/2024 | Mentor Worldwide LLC | MENTOR SILTEX Round SPECTRUM (Device) | Food and Beverage | In-kind items and services | $8.59 | General |
| Category: Plastic Surgery | ||||||
| 05/23/2024 | Stryker Corporation | NA (Device) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: CRANIOMAXILLOFACIAL | ||||||
| 12/11/2023 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 11/09/2023 | AbbVie Inc. | ALLODERM (Device) | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: PLASTIC SURGERY | ||||||
| 05/31/2023 | AbbVie Inc. | NATRELLE SALINE-FILLED BREAST IMPLANTS (Device) | Food and Beverage | In-kind items and services | $139.00 | General |
| Category: PLASTIC SURGERY | ||||||
| 03/15/2023 | AbbVie Inc. | NATRELLE SALINE-FILLED BREAST IMPLANTS (Device) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: PLASTIC SURGERY | ||||||
| 10/21/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $51.45 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/21/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $48.66 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/21/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $39.20 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/20/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $48.66 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/20/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $44.31 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/20/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $39.20 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/12/2022 | Janssen Biotech, Inc. | PREZCOBIX (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 07/20/2022 | Janssen Biotech, Inc. | PREZCOBIX (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 12/13/2021 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $31.49 | General |
| Category: Respiratory | ||||||
| 06/24/2021 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: HIV | ||||||
| 03/04/2021 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: HIV | ||||||
| 10/09/2020 | Allergan, Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/28/2020 | Allergan, Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/06/2020 | Allergan, Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 566 | 1,045 | $317,469 | $83,962 |
| 2022 | 6 | 528 | 923 | $285,872 | $72,423 |
| 2021 | 6 | 697 | 1,130 | $354,712 | $92,290 |
| 2020 | 5 | 712 | 1,142 | $351,913 | $93,241 |
Total Patients
2,503
Total Services
4,240
Medicare Billing
$341,917
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 213 | 547 | $123,129 | $33,718 | 27.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 145 | 257 | $84,812 | $24,042 | 28.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 105 | 114 | $67,545 | $15,423 | 22.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 39 | 44 | $18,280 | $4,482 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 43 | $14,217 | $3,639 | 25.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 40 | $9,486 | $2,659 | 28.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 188 | 429 | $94,809 | $24,068 | 25.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 162 | 285 | $90,915 | $22,967 | 25.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 107 | 109 | $67,580 | $16,513 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 67 | $21,708 | $6,001 | 27.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 18 | $7,560 | $1,940 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 15 | $3,300 | $933.02 | 28.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 232 | 371 | $118,349 | $30,518 | 25.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 222 | 495 | $109,395 | $28,492 | 26.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 133 | 134 | $83,080 | $21,378 | 25.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 56 | 72 | $23,328 | $6,349 | 27.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 38 | 39 | $16,380 | $4,164 | 25.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 19 | $4,180 | $1,388 | 33.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 288 | 626 | $138,346 | $36,986 | 26.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 147 | 148 | $91,760 | $24,567 | 26.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 191 | 253 | $80,707 | $21,408 | 26.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 46 | 75 | $24,300 | $5,847 | 24.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 40 | 40 | $16,800 | $4,433 | 26.4% |
About Dr. Ashley Thomas, MD
Dr. Ashley Thomas, MD is a Infectious Disease healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/01/2008. The National Provider Identifier (NPI) number assigned to this provider is 1578714135.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashley Thomas, MD has received a total of $1,515 in payments from pharmaceutical and medical device companies, with $199.48 received in 2024. These payments were reported across 42 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,328).
As a Medicare-enrolled provider, Thomas has provided services to 2,503 Medicare beneficiaries, totaling 4,240 services with total Medicare billing of $341,917. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Orlando, FL
- Active Since 10/01/2008
- Last Updated 11/14/2016
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1578714135
Products in Payments
- BOTOX (Biological) $271.48
- NATRELLE SALINE-FILLED BREAST IMPLANTS (Device) $156.32
- ZERBAXA (Drug) $123.59
- Biktarvy (Drug) $120.51
- MENTOR MemoryGel Resterilizable Gel Sizer (Device) $111.21
- DIFICID (Drug) $106.59
- ZINPLAVA (Biological) $97.38
- DALVANCE (Drug) $53.99
- Arikayce (Drug) $47.73
- PREZCOBIX (Drug) $43.78
- TEFLARO (Drug) $42.42
- ALLODERM (Device) $35.07
- MENTOR CPX 2 Breast Tissue Expander (Device) $32.99
- NA (Device) $22.04
- DOVATO (Drug) $21.43
- Heplisav-B (Drug) $21.25
- CABENUVA (Biological) $17.93
- Imbruvica (Drug) $16.59
- AVYCAZ (Drug) $14.66
- CONTRAVE (Drug) $10.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Orlando
Dr. Charlotte-Paige Rolle, M.d, M.D
Infectious Disease — Payments: $520,539
Infectious Disease $520,539
Federico Hinestrosa, Md, MD
Infectious Disease — Payments: $331,463
Infectious Disease $331,463
Vincent Hsu, Md, MD
Infectious Disease — Payments: $199,883
Infectious Disease $199,883
Edwin Dejesus, Md, MD
Infectious Disease — Payments: $132,951
Infectious Disease $132,951
Patricia Couto, M.d, M.D
Infectious Disease — Payments: $22,106
Infectious Disease $22,106
Dr. William Robbins, M.d, M.D
Infectious Disease — Payments: $19,785
Infectious Disease $19,785